Therapeutic role of glutamine in management of radiation enteritis: a meta-analysis of 13 randomized controlled trials

De-dong Cao; Hui-lin Xu; Min Xu; Xiang-yun Qian; Zhu-cheng Yin; Wei Ge

doi:10.18632/oncotarget.15741

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Reviews:

Therapeutic role of glutamine in management of radiation enteritis: a meta-analysis of 13 randomized controlled trials

De-dong Cao, Hui-lin Xu, Min Xu, Xiang-yun Qian, Zhu-cheng Yin and Wei Ge _

PDF | HTML | How to cite

Oncotarget. 2017; 8:30595-30605. https://doi.org/10.18632/oncotarget.15741

Metrics: PDF 2157 views | HTML 2924 views | ?

Abstract

De-dong Cao1, Hui-lin Xu2, Min Xu1, Xiang-yun Qian1, Zhu-cheng Yin1 and Wei Ge1

1 Department of Oncology, RenMin Hospital of WuHan University, WuHan, Hubei, P.R. China

2 Department of Oncology, The Fifth Hospital of Wuhan, Wuhan, P.R. China

Correspondence to:

Wei Ge, email:

Keywords: radiation enteritis; glutamine; radiotherapy; meta-analysis; evidence based medicine

Received: December 10, 2016 Accepted: February 07, 2017 Published: February 25, 2017

Abstract

Objective: To systematically evaluate the clinical efficacy of glutamine in treating radiation enteritis in cancer patients treated with radiotherapy.

Methods: Electronic databases including Pubmed, Embase, the Cochrane library, and CNKI were systematically searched, until April 2016. Randomized controlled trials (RCT) of glutamine in the treatment of radiation enteritis in cancer patients were searched, and RevMan 5.3 software was used for Meta-analysis.

Results: A total of 13 RCTs were included, involving 979 patients. The results of meta-analysis showed that the total efficacy of glutamine was higher for patients with radiation enteritis compared with that in control group, however, there was no statistically significant difference(OR = 3.07, 95%CI: 0.79-11.96; P > 0.05). The combined ORs for all 5 grades(from grade 0 to grade 4) of radiation enteritis in patients receiving glutamine were 2.06, 1.35, 0.55, 0.62 and 0.59, respectively(P > 0.05 for all). Glutamine also failed to significantly improve the symptoms of radiation enteritis in terms of tenesmus, abdominal cramping and blood in bowel movement(P > 0.05).

Conclusions: Implementation of glutamine fails to improve the severity and symptoms in patients with radiation enteritis.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 15741

Publication Alerts

Reviews:

Therapeutic role of glutamine in management of radiation enteritis: a meta-analysis of 13 randomized controlled trials

Abstract